Backed by decades of research.
Vibroacoustic therapy has a substantial and growing body of peer-reviewed evidence. Here is what the science shows.
How it works
Vibroacoustic therapy works by delivering low-frequency sound vibrations, typically between 30 and 120 Hz, directly through a surface the person lies on. Unlike listening to music through speakers, the vibrations are felt physically throughout the body.
The science behind this has been building since the late 1970s, when Norwegian researcher Olav Skille began documenting the physiological effects of low-frequency vibration on the body. His early clinical work, conducted with patients experiencing chronic pain and muscle disorders, found that targeted vibration produced measurable reductions in tension and discomfort. Skille's research established the foundation for what is now a substantial body of peer-reviewed literature.
The effect is not mediated by belief or expectation. It is a physiological response to a physical stimulus.
A measurable shift in the nervous system.
Low-frequency vibration activates the sensory nerve endings that respond to physical pressure and movement. This activation triggers the parasympathetic nervous system: the part responsible for rest, recovery and calm. Cortisol levels fall. Heart rate slows. Muscle tension releases.
Studies have examined vibroacoustic therapy across chronic pain, fibromyalgia, Parkinson's disease, post-operative recovery, anxiety, and neurodivergent sensory dysregulation. Aalborg University in Denmark, one of the world's leading centres for music therapy research, has been at the forefront of this work. The consensus is consistent: when applied at the right frequencies, vibroacoustic stimulation produces a reliable, reproducible shift in the nervous system from a state of activation toward a state of rest.
When applied at the right frequencies, vibroacoustic stimulation can support positive feelings of relaxation, help you find a state of focus, and encourage somatic regulation.
Key research.
View all 261 on PubMed →VibroAcoustic Therapy
The foundational paper that established vibroacoustic therapy as a clinical discipline. Skille documented physiological effects of low-frequency vibration across patients with chronic pain and muscle disorders, laying the groundwork for four decades of subsequent research.
Learn more →The Effect of Vibroacoustic Therapy on Clinical and Non-Clinical Populations
Wigram's landmark doctoral research examined the measurable physiological effects of VAT across both clinical and general populations, establishing robust evidence for its application in pain management, anxiety reduction and neurological conditions.
Learn more →Cognitive Rehabilitation Among Long COVID Patients Using Vibratory and Auditory Treatment Is Linked to BDNF
A 2025 study demonstrating that vibratory and auditory treatment produced measurable cognitive improvement in long COVID patients, with changes linked to BDNF — a protein associated with neuroplasticity and brain health.
Learn more →Acoustic Stimulation in Pain Management: Neurobiological Mechanisms and Clinical Applications
A comprehensive narrative review examining how acoustic and vibroacoustic stimulation produces analgesic effects through neurobiological pathways, with evidence across multiple pain conditions as an alternative to pharmacological intervention.
Learn more →Effects of Vibroacoustic Stimulation on Hypertension: A Pilot Cross-Over Experimental Study
A controlled pilot study examining the impact of vibroacoustic stimulation on blood pressure in hypertensive patients, contributing to the growing evidence base for VAT's cardiovascular and autonomic nervous system effects.
Learn more →Vibroacoustic Therapy and Parkinson's Disease
A body of research examining the use of low-frequency vibration in managing Parkinson's symptoms, including tremor, rigidity and gait disturbance, with several studies documenting meaningful improvements in motor function and quality of life.
Read a key study →